Industry: 'Cures' Expanded Access Proposal Might Stifle Trial Enrollment

The expanded access provisions contained within the 21st Century Cures draft bill -- which would require drug companies to be more transparent when it comes to expanded access decisions -- garnered support from patient groups but two drug companies raised concerns the measure could stifle patients' willingness to join clinical studies. The expanded access measure is viewed as a federal alternative to "Right to Try" laws, passed by more than 10 states, that House Energy and Commerce Committee staffers likewise...